Ellen S. Lewis
1331 29th St, NW
Calgary, AB T2N4N2, Canada
Calgary, AB T2N4N2, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
BCMA CAR-T: From Multiple Myeloma to Light-Chain Amyloidosis.
Journal: Current oncology (Toronto, Ont.)
Published: June 13, 2025
Reporting a Homozygous Case of Neurodevelopmental Disorder Associated With a Novel PRPF8 Variant.
Journal: Molecular genetics & genomic medicine
Published: October 01, 2024
Doxycycline Plus Bortezomib-Containing Regimens for the Treatment of Light-Chain Amyloidosis in the Frontline Setting: Experience from the Amyloidosis Program of Calgary.
Journal: Current oncology (Toronto, Ont.)
Published: August 22, 2024
Daratumumab for the treatment of relapsed/refractory AL amyloidosis: experience from the amyloidosis Program of Calgary (APC).
Journal: Leukemia & lymphoma
Published: December 06, 2023
Effect of the Presence of t(11;14) for Patients With AL Amyloidosis Treated With Bortezomib-Containing Regimens: Experience From the Amyloidosis Program of Calgary.
Journal: Clinical lymphoma, myeloma & leukemia
Published: May 30, 2023
Monoclonal Gammopathy of Undetermined Significance in Patients With Transthyretin Amyloidosis (ATTR): Analysis Using the iStopMM Criteria.
Journal: Clinical lymphoma, myeloma & leukemia
Published: August 17, 2022
Amyloidosis and COVID-19: experience from an amyloid program in Canada.
Journal: Annals of hematology
Published: May 05, 2022
Treating CLL with Bruton Tyrosine Kinase Inhibitors: The Role of the Outpatient Oncology Nurse.
Journal: Seminars in oncology nursing
Published: July 20, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026